Stockscreener 앱 받기
6.06
2.88%
-0.18
시간 외 거래:
6.06
전일 마감가:
$6.24
열려 있는:
$6.18
하루 거래량:
80,899
Relative Volume:
0.09
시가총액:
$16.01M
수익:
$500.00K
순이익/손실:
$-19.45M
주가수익비율:
-3.2063
EPS:
-1.89
순현금흐름:
$-18.22M
1주 성능:
-6.63%
1개월 성능:
-0.44%
6개월 성능:
-42.64%
1년 성능:
-59.95%
1일 변동 폭
$5.85
$6.3893
1주일 범위
$5.85
$6.96
52주 변동 폭
$4.8261
$41.22
Imunon Inc Stock (IMNN) Company Profile
명칭
Imunon Inc
전화
(609) 896-9100
주소
997 LENOX DRIVE, LAWRENCEVILLE
IMNN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
6.06 | 16.01M | 500.00K | -19.45M | -18.22M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.50 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Imunon Inc 주식(IMNN)의 최신 뉴스
How to integrate Imunon Inc. into portfolio analysis toolsJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - Newser
Predicting Imunon Inc. trend using moving averagesQuarterly Profit Summary & High Accuracy Trade Signal Alerts - Newser
Imunon Inc. stock momentum explained2025 EndofYear Setup & Safe Swing Trade Setups - Newser
Will breakout in Imunon Inc. lead to full recoveryGold Moves & Long-Term Growth Portfolio Plans - Newser
What’s the recovery path for long term holders of Imunon Inc.July 2025 Movers & Daily Stock Trend Reports - Newser
Is it too late to sell Imunon Inc.Gap Up & Daily Growth Stock Tips - Newser
Real time breakdown of Imunon Inc. stock performanceLong Setup & Technical Pattern Alert System - Newser
Is Imunon Inc. still worth holding after the dipNew Guidance & Free Safe Entry Trade Signal Reports - Newser
When is the best time to exit Imunon Inc.2025 Geopolitical Influence & Long Hold Capital Preservation Plans - Newser
What candlestick patterns are forming on Imunon Inc.Market Risk Summary & Expert Verified Movement Alerts - Newser
Can Imunon Inc. ride the EV waveMarket Growth Report & Consistent Profit Trading Strategies - theviewers.co.kr
Momentum divergence signals in Imunon Inc. chartEarnings Summary Report & Free Real-Time Volume Trigger Notifications - Newser
Can Imunon Inc. expand its profit margins2025 Growth vs Value & Technical Confirmation Alerts - theviewers.co.kr
Can momentum traders help lift Imunon Inc.Weekly Investment Recap & Community Supported Trade Ideas - Newser
Will Imunon Inc. outperform the market2025 Price Momentum & Target Return Focused Stock Picks - Newser
Key metrics from Imunon Inc.’s quarterly dataEarnings Beat & Low Drawdown Investment Strategies - Newser
Is Imunon Inc. benefiting from innovation trendsJuly 2025 Retail & Daily Growth Stock Tips - theviewers.co.kr
Published on: 2025-08-20 20:32:23 - Newser
Can Imunon Inc. Bounce Back From Weekly LowWeekly Loss Report & Long-Term Growth Stock Strategies - 더경남뉴스
Imunon Inc. Rebounds From Oversold Zone — Now WhatDollar Strength & Verified Entry Point Detection - newsyoung.net
Trend Reversal Possible in Imunon Inc. Charts IndicateJuly 2025 Momentum & Weekly Market Pulse Updates - kangso.co.kr
Is Imunon Inc. trading at a discountJuly 2025 Catalysts & Fast Moving Stock Watchlists - kangso.co.kr
Is a relief rally coming for Imunon Inc. holdersJuly 2025 Action & Risk Managed Trade Strategies - Newser
Is now a turning point for Imunon Inc.2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - Newser
Is Imunon Inc. a strong candidate for buy and hold2025 Market Outlook & Fast Moving Trade Plans - classian.co.kr
Sentiment analysis tools applied to Imunon Inc.Market Trend Review & AI Driven Stock Reports - Newser
Earnings Chart Overlay Points to Imunon Inc. UpsideJuly 2025 Price Swings & Real-Time Volume Trigger Notifications - sundaytimes.kr
IMUNON launches up to $9.75M securities offering - MSN
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment - MSN
Tools to monitor Imunon Inc. recovery probabilityWeekly Profit Report & Growth Focused Entry Reports - Newser
How to escape a deep drawdown in Imunon Inc.2025 Geopolitical Influence & AI Enhanced Trading Signals - Newser
How Imunon Inc. stock performs during market volatilityPortfolio Profit Report & Fast Gain Swing Alerts - Newser
What are the future prospects of Imunon Inc.July 2025 Short Interest & Free Fast Gain Swing Trade Alerts - mustnews.co.kr
Can Imunon Inc. Regain Lost Ground This QuarterTrade Entry Summary & Real-Time Volume Analysis - classian.co.kr
Trendlines Converge — Decision Point for Imunon Inc.Market Risk Summary & Fast Momentum Stock Entry Tips - sundaytimes.kr
Imunon, Inc.’s Phase II Study on IMNN-001: A Potential Game-Changer in Ovarian Cancer Treatment? - TipRanks
Imunon, Inc.’s Ongoing Clinical Trial: Potential Game-Changer for Ovarian Cancer Treatment? - TipRanks
Is Imunon Inc. meeting your algorithmic filter criteriaJuly 2025 Recap & Capital Protection Trade Alerts - Newser
New Product Launches: Will They Boost Imunon Inc. Stock in 2025Free Growth Based Stock Signal Screener - Newser
Imunon, Inc. Advances Cancer Treatment with Phase 3 Trial of IMNN-001 - TipRanks
Can Imunon Inc. outperform under higher oil pricesMassive Earnings Growth Picks - sisaissue.com
How high can Imunon Inc. stock goLong Hold Investment Strategy with Growth Focus - Newser
Imunon, Inc. Earnings Call Highlights Progress and Challenges - MSN
Imunon (NASDAQ:IMNN) Upgraded by Wall Street Zen to Hold Rating - Defense World
Analysts Set Expectations for Imunon Q3 Earnings - Defense World
IMNN: First Patient Dosed in Phase 3 OVATION 3 Trial… - Zacks Small Cap Research
Imunon, Inc. shares fall 4.57% intraday despite announcing a 15% stock dividend payment. - AInvest
Imunon, Inc. (NASDAQ:IMNN) Q2 2025 Earnings Call Transcript - Insider Monkey
Imunon Inc (IMNN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance
Imunon Inc (IMNN) Q2 2025 Earnings Call Highlights: Strategic Ad - GuruFocus
Imunon Inc (IMNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
8.06%
자본화:
|
볼륨(24시간):